These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. Bradding P; Feather IH; Wilson S; Bardin PG; Heusser CH; Holgate ST; Howarth PH J Immunol; 1993 Oct; 151(7):3853-65. PubMed ID: 8376806 [TBL] [Abstract][Full Text] [Related]
25. [Observation of the response of antigen in the basophilic cells in nasal mucosa in patients with allergic rhinitis]. Zheng H Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(6):347-9, 385. PubMed ID: 3153766 [No Abstract] [Full Text] [Related]
26. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777 [TBL] [Abstract][Full Text] [Related]
27. [Cytodiagnosis in allergic rhinitis]. Makowska W; Zawisza E Pol Tyg Lek; 1977 Aug; 32(34):1345-6. PubMed ID: 333415 [No Abstract] [Full Text] [Related]
29. Interferon-alpha affects the tumour necrosis factor-alpha content of mast cells in human nasal mucosa. A pilot study in allergic patients. Riccardi-Arbi R; Bacci S; Romagnoli P; Rucci L Ital J Anat Embryol; 2004; 109(2):115-22. PubMed ID: 15481160 [TBL] [Abstract][Full Text] [Related]
30. Gene and protein expression of protease-activated receptor 2 in structural and inflammatory cells in the nasal mucosa in seasonal allergic rhinitis. Dinh QT; Cryer A; Trevisani M; Dinh S; Wu S; Cifuentes LB; Feleszko WK; Williams A; Geppetti P; Fan Chung K; Heppt W; Klapp BF; Fischer A Clin Exp Allergy; 2006 Aug; 36(8):1039-48. PubMed ID: 16911360 [TBL] [Abstract][Full Text] [Related]
31. [Nasal hyperreactivity. Allergic rhinitis and its differential diagnoses. Consensus report of pathophysiology, classification, diagnosis and therapy]. HNO; 1997 Apr; 45(4):189-201. PubMed ID: 9221257 [No Abstract] [Full Text] [Related]
32. IgE-Fc epsilonRI-mast cell axis in the allergic cycle. Pawankar R; Ra C Clin Exp Allergy; 1998 Aug; 28 Suppl 3():6-14. PubMed ID: 9756181 [TBL] [Abstract][Full Text] [Related]
33. Immunoreactive respiratory basophil-like cells and mast cells. Patterson R; Tomita Y; O S; Suszko IM; Pruzansky JJ Trans Assoc Am Physicians; 1973; 86():95-101. PubMed ID: 4132984 [No Abstract] [Full Text] [Related]
37. Treatment of allergic rhinitis. Okuda M Asian Pac J Allergy Immunol; 1983 Dec; 1(2):170-4. PubMed ID: 6681010 [No Abstract] [Full Text] [Related]
38. [Recent study on nasal allergy. (6). A study of degranulation of rat mast cells caused by antigen-antibody complex of the nasal secretion]. Miyashita H; Ishikawa K; Shimada T Nihon Jibiinkoka Gakkai Kaiho; 1974 Jul; 77(7):514-9. PubMed ID: 4475100 [No Abstract] [Full Text] [Related]
39. [Mast cells in the nasal secretions of patients with chronic rhinitis and rhinosinusitis]. Gerber VKh; Elykomov AA Vestn Otorinolaringol; 1973; 34(4):52-6. PubMed ID: 4713900 [No Abstract] [Full Text] [Related]
40. [Etiopathogenesis and clinical aspects of allergic and vasomotor rhinopathy]. Mira E Recenti Prog Med; 1989; 80(7-8):377-82. PubMed ID: 2682853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]